Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,243 | 82 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $317.51 | 21 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $236.35 | 15 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $158.01 | 10 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $115.17 | 9 | $0 (2020) |
| Lilly USA, LLC | $104.50 | 7 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $36.29 | 2 | $0 (2020) |
| Allergan, Inc. | $34.98 | 2 | $0 (2020) |
| Eisai Inc. | $33.87 | 2 | $0 (2020) |
| Amarin Pharma Inc. | $33.49 | 2 | $0 (2020) |
| Alcon Laboratories Inc | $32.74 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $602.21 | 40 | Novo Nordisk Inc ($168.60) |
| 2019 | $270.54 | 18 | Novo Nordisk Inc ($69.78) |
| 2018 | $126.81 | 7 | SANOFI-AVENTIS U.S. LLC ($42.61) |
| 2017 | $243.66 | 17 | SANOFI-AVENTIS U.S. LLC ($117.72) |
All Payment Transactions
82 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/10/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 12/08/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $13.34 | General |
| Category: Neurology | ||||||
| 12/03/2020 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Obesity | ||||||
| 12/01/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Diabetes | ||||||
| 11/24/2020 | Lilly USA, LLC | REYVOW (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Neuroscience | ||||||
| 11/23/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/05/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.31 | General |
| Category: DIABETES | ||||||
| 11/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2020 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Endocrinology | ||||||
| 10/27/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Diabetes | ||||||
| 09/22/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: UROLOGY | ||||||
| 09/21/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Cardiovascular | ||||||
| 09/15/2020 | DERMIRA, INC. | QBREXZA (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: DERMATOLOGY | ||||||
| 09/10/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: DIABETES | ||||||
| 09/09/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Diabetes | ||||||
| 09/02/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/24/2020 | Eisai Inc. | Dayvigo (Drug) | Food and Beverage | Cash or cash equivalent | $20.53 | General |
| Category: Neurology | ||||||
| 08/18/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Diabetes | ||||||
| 08/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Diabetes | ||||||
| 08/03/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: RESPIRATORY | ||||||
| 07/30/2020 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: UROLOGY | ||||||
| 07/28/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/28/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.69 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 12 | 552 | 755 | $112,145 | $36,950 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 136 | 136 | $42,432 | $15,091 | 35.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 154 | 323 | $42,959 | $12,945 | 30.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 42 | 42 | $3,906 | $2,561 | 65.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 36 | $7,092 | $2,222 | 31.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2020 | 11 | 12 | $3,624 | $1,705 | 47.1% |
| 82274 | Stool analysis for blood | Office | 2020 | 41 | 42 | $2,856 | $665.76 | 23.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 42 | 42 | $2,814 | $660.66 | 23.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 13 | $1,040 | $361.95 | 34.8% |
| 69210 | Removal of impact ear wax, one ear | Office | 2020 | 14 | 15 | $2,145 | $328.94 | 15.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 28 | 41 | $2,747 | $272.25 | 9.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 21 | 24 | $240.00 | $72.04 | 30.0% |
| 81003 | Automated urinalysis test | Office | 2020 | 20 | 29 | $290.00 | $64.90 | 22.4% |
About Dr. Robert Pilkinton, MD
Dr. Robert Pilkinton, MD is a Family Medicine healthcare provider based in Goodlettsville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386707446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Pilkinton, MD has received a total of $1,243 in payments from pharmaceutical and medical device companies, with $602.21 received in 2020. These payments were reported across 82 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,243).
As a Medicare-enrolled provider, Pilkinton has provided services to 552 Medicare beneficiaries, totaling 755 services with total Medicare billing of $36,950. Data is available for 1 year (2020–2020), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Goodlettsville, TN
- Active Since 12/19/2006
- Last Updated 09/05/2019
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386707446
Products in Payments
- Ozempic (Drug) $185.02
- JARDIANCE (Drug) $126.89
- TRULICITY (Drug) $87.57
- FARXIGA (Drug) $86.52
- Victoza (Drug) $79.13
- SOLIQUA (Drug) $72.68
- TOUJEO (Drug) $69.84
- SOLIQUA 100/33 (Biological) $42.47
- Tresiba (Drug) $36.28
- VRAYLAR (Drug) $34.98
- Dayvigo (Drug) $33.87
- Vascepa (Drug) $33.49
- MYRBETRIQ (Drug) $29.00
- BYDUREON (Drug) $28.65
- XIFAXAN (Drug) $26.28
- JANUVIA (Drug) $20.69
- SOLIQUA 100/33 (Drug) $19.36
- QBREXZA (Drug) $19.23
- SPIRIVA RESPIMAT (Drug) $19.09
- Centurion (Device) $18.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Goodlettsville
Dr. Megan Settle, Md, MD
Family Medicine — Payments: $35,322
Dr. Ted Miller, M.d, M.D
Family Medicine — Payments: $7,885
Dr. Robert Ferland, M.d, M.D
Family Medicine — Payments: $7,568
Dr. Donald Spisak, Do, DO
Family Medicine — Payments: $6,212
Dr. James Botsko, M.d, M.D
Family Medicine — Payments: $2,677
Dr. John Baites,, M.d, M.D
Family Medicine — Payments: $776.02